- Online only
10CFU® Mycoplasma Standards are inactivated, non-infectious, lyophilized mycoplasma particles designed as reference material for product-specific validation of PCR-based mycoplasma testing methods.
- Compliant with EP 2.6.7 (12.2), USP <77>, and JP 18 G3
- Defined concentration of ≤10 CFU/ml, GC:CFU ratio <10
- Suitable for product-specific validation and for use as EPC/EIC
Cat. no.: 105-3001
Validation Guide for 10CFU® Mycoplasma gallisepticum
Please use this form to request a validation guide.
All fields are required. Please use your business contact data.
Please provide your first name. Please provide your last name. The e-mail seems to be missing or incorrect. Please provide your company/institution. Send Validation GuideMycoplasma contamination represents one of the most critical risks in cell culture systems and biopharmaceutical manufacturing, including ATMPs. The European Pharmacopoeia (EP) 2.6.7, the United States Pharmacopeia (USP) <77>, and the Japanese Pharmacopoeia (JP) 18 G3 require validated test methods capable of detecting both cultivable and non-cultivable mycoplasma.
10CFU® Mycoplasma Standards were specifically developed to meet these regulatory requirements. Manufactured in accordance with EP 2.6.7 (edition 12.2), the standards are non-infectious and safe to handle. After reconstitution, defined quantities of the standard are spiked into the respective product or sample matrix to enable Limit of Detection (LOD) determination and use as an External Positive Control (EPC) with a defined concentration.
Mycoplasma gallisepticum is a characteristic avian mycoplasma species and is particularly associated with processes involving poultry- or egg-derived materials. The 10CFU® Mycoplasma gallisepticum standard is therefore especially suitable for matrix-specific, risk-based validation of NAT-based mycoplasma testing in manufacturing processes with avian origin.
| Product category | 10CFU® Mycoplasma Standards |
|---|---|
| Species | Mycoplasma gallisepticum (Mycoplasmoides gallisepticum) |
| Sample type | Inactivated mycoplasma particles (DNA/RNA-containing) |
| NCTC code | 10115 |
| ATCC code | 19610 |
| Application | NAT-based mycoplasma testing |
| Application areas |
|
| Regulatory compliance | EP 2.6.7 (12.2), USP <77>, JP 18 G3 |
| Contents |
|
| Detection method |
|
| Required equipment & consumables |
|
| Concentration | ≤10 CFU/ml |
| Storage | 2-8 °C |
| Shipping | Ambient temperature |
| Shelf life | See package labeling |
Cat. No. 105-1001: Mycoplasma arginini
Cat. No. 105-2001: Mycoplasma orale
Cat. No. 105-4001: Mycoplasma pneumoniae
Cat. No. 105-5001: Mycoplasma synoviae
Cat. No. 105-6001: Mycoplasma fermentans
Cat. No. 105-7001: Mycoplasma hyorhinis
Cat. No. 105-8001: Acholeplasma laidlawii
Cat. No. 105-9001: Spiroplasma citri
Cat. No. 105-1101: Mycoplasma salivarium